PHIBRO (PAHC) CFO David Glenn Receives RSU Award

What Happened

• David Glenn, Chief Financial Officer of Phibro Animal Health Corp (PAHC), was granted 3,334 restricted stock units (RSUs) on August 6, 2026. The RSUs were awarded at a grant price of $0.00 (total reported value $0) and represent a contingent right to receive one share of Class A common stock per RSU. This is a compensation award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-06; Form 4 filed: 2026-08-10 (filed within the two-business-day window).
• Award: 3,334 RSUs granted @ $0.00 (reported acquisition value $0).
• Post-transaction holdings: not specified in the provided filing excerpt.
• Footnotes:
  • F1: Each RSU converts to one share of Class A common stock upon settlement.
  • F2: RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to continued employment.
• No 10b5-1 plan, immediate sale, or tax-withholding disposition reported in this filing.

Context

• RSUs are a form of equity compensation that convert to shares only upon vesting; they do not represent immediate share ownership or an out-of-pocket purchase by the insider. Such grants are routine as part of executive compensation and retention programs and should not be interpreted as a direct market buy or sell decision.